Some of the most common cancers, such as those of the breast and prostate, grow at least in part as a result of hormones acting at hormone receptors on cancer cells within the body. Growth of these cancer cells can often be halted or slowed dramatically with hormonal therapy medicines that inhibit (block) action of hormones on these receptors. These agents may be delivered orally (PO; by mouth), intravenously (IV; by vein), or subcutaneously (SQ; under the skin). They may be delivered before, during, or after radiation therapy (RT) or surgery. They can be extremely effective anticancer agents and can improve patients' survival significantly.
Some of the most common cancers, such as those of the breast and
prostate, grow at least in part as a result of hormones acting at
hormone receptors on cancer cells within the body. Growth of these
cancer cells can often be halted or slowed...
More